Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Studium zum Meisterkurs „Autoimmunintervention“. (AIM)

15. September 2026 aktualisiert von: Terry L. Wahls

Evaluierung eines Online-Kurses zur Unterstützung der Einführung gesünderer Ernährungs- und Selbstpflegeroutinen bei Multiple-Sklerose-Patienten

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.

Studienübersicht

Status

Aktiv, nicht rekrutierend

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remissin with persisting fatigue. The cancer patients must be patients at the University of Iowa Holden Cancer Center.

Once eligibility criteria are determined and consent is obtained, participants would work through the course modules like a non-graded online course. There are exercises and personal assessments within the course participants are asked to take to build upon each other to increase the success of the experience while taking the course.

Throughout the course there will be modules that will discuss an inner game plan, food intervention plan, physical intervention plan, and an increased resilience plan. The fourth module suggests different strategies that participants can do to improve their health beyond food and exercise. These types of things would include supplements, light therapy, detoxification, improved sleep, stress reduction, and other ways to enhance their body's resilience.

Investigators ask that participants inform and work with their healthcare team to personalize their treatment and determine if the suggested strategies mentioned in the course are appropriate for their healthcare path. This will provide dietary education to a larger sample size compared to what has been studied in the past. The study may include more patients that have limited resources, including but not limited to, money and location for access to registered dietitians with expertise in dietary instruction for patient s diagnosed with multiple sclerosis and CIS. There is interest in education and support that can be delivered via an online platform that can lead to improved diet quality and self-care routines for multiple sclerosis and autoimmune patients.

This study will use a randomized single-blind wait list control design to evaluate the impact of an online course that teaches the modified Paleolithic diet, nutrient dense vegetarian diet and Mediterranean diets, stress reduction and exercise strategies using commercially available online course for autoimmune patients. Data will be collected in the short-term (after 3 months) and long-term (at the end of 6 months ) to analyze the impact of an online wellness program QoL and related outcomes among people with CIS and MS, fibromyalgia, post acute sequela of covid, and cancer in remission wiht persisting fatigue.

The study will use a 7-day window to collect baseline assessments. Participants will use a personal email that does not contain identifying information to participate in the study. Participants will be asked to complete all baseline assessments. This email and password will be used for access to the online course materials. Patients will be randomized to the intervention arm based upon the baseline modified fatigue impact score.

Patients will receive access to the online program and 7 group support videos (released one per week or 7 weeks total). Participants will access the course materials using the study assigned email.

The proposed study will consist of virtual-only participants and will have 3 virtual visits every 3 months (months 0, 3, and 6). Online questionnaires will be sent to the participants to assess fatigue and quality of life. Dietary assessments will include a questionnaire through a web-based tool after baseline, at month 3, and month 6.

Studientyp

Interventionell

Einschreibung (Geschätzt)

400

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 100 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • self-reported multiple sclerosis
  • self-reported clinically isolated syndrome

OR self-reported post-acute sequelae of COVID (PASC), also known as long COVID, with a confirmed laboratory test of COVID-19 infection, persisting fatigue and neuropsychiatric symptoms for longer than 6 months after confirmation of COVID diagnosis,

OR self-reported diagnosis of fibromyalgia as documented by their treating specialist or primary care provider,

Exclusion Criteria:

-

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: Zufällig
  • Interventionsmodell: Crossover-Aufgabe
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Intervention Autoimmune Intervention Mastery Course (AIM) online course

This arm will begin the intervention immediately after randomization

Immediate access to an on line audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care

Andere Namen:
  • AIM-Kurs

Immediate access to videos answering common questions about the course concepts. One video released each week, 7 videos total.

Andere Namen:
  • AIM-Frage-und-Antwort-Sitzungen
Sonstiges: Delayed Autoimmune Intervention Mastery Course

This is the control arm.

Delayed access to an on line audio and video course with education about strategies to grow and improve resilience, diet quality, exercise, stress reduction and self-care

Delayed access to videos answering common questions about the course concepts. One video released each week, 7 videos total.

Andere Namen:
  • Verspätete AIM-Frage-und-Antwort-Sitzungen

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Multiple Sclerosis 54 Quality of Life Mental Health (MS 54 QoL MH)
Zeitfenster: baseline to 3 months

Change in (MS 54 QoL MH) survey questions mean scores, range 0-100, higher number is better.

baseline to 3 months
Multiple Sclerosis 54 Quality of Life Mental Health (MS 54 QoL MH)
Zeitfenster: baseline to 6months

Change in (MS 54 QoL MH) survey questions mean scores, range 0-100, higher number is better.

baseline to 6months
Multiple Sclerosis 54 Quality of Life Physical Health (MS 54 QoL PH)
Zeitfenster: baseline to 3 months

Change in (MS 54 QoL PH) survey questions mean scores, range 0-100, higher number is better.

baseline to 3 months
Multiple Sclerosis 54 Quality of Life Physical Health (MS 54 QoL PH)
Zeitfenster: baseline to 6 months

Change in (MS 54 QoL PH) survey questions mean scores, range 0-100, higher number is better.

baseline to 6 months
Short form 36 (SF 36)
Zeitfenster: baseline to 3 months

Change in (SF 36) survey questions mean scores, range 0-100, higher number is better.

baseline to 3 months
Short form 36 (SF 36)
Zeitfenster: baseline to 6 months

Change in (SF 36) survey questions mean scores, range 0-100, higher number is better.

baseline to 6 months
The Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-FS):
Zeitfenster: baseline to 3 months

FACIT-FS is a 13-item measure that assesses self-reported fatigue and its impact upon daily activities and function, which can be completed in less than 5 minutes.10 Each question provides 5 ordinal response options ("not at all," "a little bit," "somewhat," "quite a bit," and "very much"). Each item contributes equally (item score range=0-4) to a total score that ranges from 0 to 52, where higher scores represent less fatigue.

baseline to 3 months
The Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-FS):
Zeitfenster: baseline to 6 months

FACIT-FS is a 13-item measure that assesses self-reported fatigue and its impact upon daily activities and function, which can be completed in less than 5 minutes.10 Each question provides 5 ordinal response options ("not at all," "a little bit," "somewhat," "quite a bit," and "very much"). Each item contributes equally (item score range=0-4) to a total score that ranges from 0 to 52, where higher scores represent less fatigue.

baseline to 6 months

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Modified Fatigue Impact Scale
Zeitfenster: baseline to 3 months

Change in MFIS survey questions, scores range from 0-84, lower score is better.

baseline to 3 months
Modified Fatigue Impact Scale
Zeitfenster: baseline to 6 months

Change in MFIS survey questions, scores range from 0-84, lower score is better.

baseline to 6 months
vegetable and fruit intake
Zeitfenster: baseline to 3 months

Change in number of servings of vegetables consumed per day, servings range from 0 to 9 or more

baseline to 3 months
vegetable and fruit intake
Zeitfenster: baseline to 6 months

Change in number of servings of vegetables consumed per day, servings range from 0 to 9 or more

baseline to 6 months
added sugar intake
Zeitfenster: baseline to 3 months

change in the grams of added sugar consumed each day, grams range from 0 to 100

baseline to 3 months
added sugar intake
Zeitfenster: baseline to 6 months

change in the grams of added sugar consumed each day, grams range from 0 to 100

baseline to 6 months
calcium intake
Zeitfenster: baseline to 3 months

change in calcium intake, range 0 to 2000 mg

baseline to 3 months
calcium intake
Zeitfenster: baseline to 6 months

change in calcium intake, range 0 to 2000 mg

baseline to 6 months
Servings of whole grains consumed
Zeitfenster: baseline to 3 months

change in number of servings of whole grains consumed, range 0 to 6 or more servings

baseline to 3 months
Servings of whole grains consumed
Zeitfenster: baseline to 6 months

change in number of servings of whole grains consumed, range 0 to 6 or more servings

baseline to 6 months
Fibromyalgia Impact Questionnaire Revised
Zeitfenster: baseline to 3 months

Pain Rating (0-10 Low to High Scale) survey questions with higher score indicating greater impact

baseline to 3 months
Fibromyalgia Impact Questionnaire Revised
Zeitfenster: baseline to 6 months

Pain Rating (0-10 Low to High Scale) survey with 15 items with higher score indicating greater impact

baseline to 6 months
Brief Pain Inventory
Zeitfenster: baseline to 3 months

Interference (0-10 Low to High Scale) 15 survey items with higher score indicating greater intensity

baseline to 3 months
Brief Pain Inventory
Zeitfenster: baseline to 6 months

Range 0-10(Low to High Scale) survey with higher score indicating greater pain intensity

baseline to 6 months
FM Disease activity (FIQR)
Zeitfenster: baseline to 3 months

0-100( Low to High Scale)21 survey items used to evaluate function, overall impact, and symptoms in patients with fibromyalgia.

baseline to 3 months
FM Disease activity (FIQR)
Zeitfenster: baseline to 6 months

0-100 (Low to High Scale)21 survey items used to evaluate function, overall impact, and symptoms in patients with fibromyalgia. High score indicating more severe symptoms.

baseline to 6 months
Pain scale
Zeitfenster: baseline to 3 months

0-10 (low to high) 13 survey items used to evaluate feelings about pain.

baseline to 3 months
Pain catastrophizing scale
Zeitfenster: baseline to 6 months

052 (low to high) 13 survey items used to evaluate feelings about pain. Higher scores indicating more severe feelings about pain related problems

baseline to 6 months
Functional Assessment of Cancer Therapy - General (FACT-G)
Zeitfenster: baseline to 3 months

measures health-related QoL covering 5 domains: physical well-being (7 items), family/social well-being (7 items), emotional well-being (6 items), functional well-being (7 items), and fatigue-specific items (13 items).10 These items are scored on a 5-point Likert scale, where 0 = "not at all" and 5 = "very much," with a recall period over the past 7 days. Domain scores can be calculated by summing the scores for each domain, and/or a total score by summing the scores for all domains, with higher scores representing better functioning. General guidelines estimate for the FACT-G minimally important difference (MID), is 4-7 points. The total score ranges from 0-108.

baseline to 3 months
Functional Assessment of Cancer Therapy - General (FACT-G)
Zeitfenster: baseline to 6 months

measures health-related QoL covering 5 domains: physical well-being (7 items), family/social well-being (7 items), emotional well-being (6 items), functional well-being (7 items), and fatigue-specific items (13 items).10 These items are scored on a 5-point Likert scale, where 0 = "not at all" and 5 = "very much," with a recall period over the past 7 days. Domain scores can be calculated by summing the scores for each domain, and/or a total score by summing the scores for all domains, with higher scores representing better functioning. General guidelines estimate for the FACT-G minimally important difference (MID), is 4-7 points. The total score ranges from 0-108.

baseline to 6 months
Optional interview at study conclusion
Zeitfenster: collected at study conclusion

Asking open ended questions about the participant's study experience, barriers, challenges, web-based aspect of course, social support, geographic location, experience with specific modules and suggestions for improvement for the course and the study

collected at study conclusion

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Hauptermittler: Terry L Wahls, MD, University of Iowa

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Dezember 2021

Primärer Abschluss (Geschätzt)

1. Dezember 2027

Studienabschluss (Geschätzt)

1. Dezember 2027

Studienanmeldedaten

Zuerst eingereicht

15. September 2021

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

15. September 2021

Zuerst gepostet (Tatsächlich)

27. September 2021

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

18. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

15. September 2026

Zuletzt verifiziert

1. August 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

Will share study data to scientists with a published PROSPERO registered meta-analysis.

IPD-Sharing-Zeitrahmen

A year after the data has been published.

IPD-Sharing-Zugriffskriterien

Scientists with a published (in a peer reviewed journal) PROSPERO meta-analysis protocol who have contacted the PI with a copy of the published protocol, their address, phone number and specific data that is being requested. The PI will review the documents and if determined appropriate, the PI will then initiate an outgoing material data use agreement with the Division of Sponsored Programs at the University of Iowa who will then contact the requesting scientist. Once the date use agreement has been signed, the data will be shared according to the terms outlined in the data use agreement.

Art der unterstützenden IPD-Freigabeinformationen

  • STUDIENPROTOKOLL
  • ICF

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .